Search For "covaxin for children"
NTAGI approves Corbevax, Covaxin for 5-12 yrs age group: Sources
Updated : 3 years, 8 months ago IST
New Delhi [India], July 8 (ANI): The National Technical Advisory Group on Immunisation's (NTAGI) Standing Technical Sub-Committee (STSC) has given a nod for the use of Biological E's Corbevax and Bharat Biotech's Covaxin for children aged between 5-12 years, sources informed on Friday.
Read More
DCGI approves COVID-19 vaccine Covaxin for children aged 6-12
Updated : 3 years, 10 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
Covaxin for Children will take some more time for final approval: Sources
Updated : 4 years, 4 months ago IST
New Delhi [India], November 8 (ANI): The data for Bharat Biotech's Covaxin for Children, COVID-19 vaccine, is under evaluation and the process will take some more time for final approval from the Drugs Controller General of India (DCGI), sources said.
Read More
Bharat Biotech's partner seeks Covaxin approval in US for children below 1
Updated : 4 years, 4 months ago IST
New Delhi [India], November 6 (ANI): Bharat Biotech's US partner Ocugen has announced that it had asked the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of Covaxin for children below 18.
Read More
Covaxin's approval for children aged 2-18 yrs under experts' opinion, eval
Updated : 4 years, 5 months ago IST
New Delhi [India], October 14 (ANI): The final approval for Bharat Biotech's Covaxin for children aged 2-18 years is under experts opinion and evaluation, stated Government sources on Thursday.
Read More
Awaiting regulatory approval for rolling out Covaxin for children aged 2-1
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): The Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's COVID-19 vaccine, Covaxin, for the beneficiaries aged between 2-18 years, the official sources said on Tuesday
Read More
Approval to Covaxin for children aged between 2-18 years awaited after eva
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
Read More
COVID-19: Subject Expert Committee gave recommendation to DCGI to use Cova
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's COVID-19 vaccine Covaxin for the beneficiaries aged between 2-18 years, the official sources said.
Read More